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β-actin (Noxa) Figure S8 . Effect of S-55746 and panobinostat on MCL1 and NOXA protein levels in DLBCL.
Western blot showing enhanced decrease in MCL1 protein level and increase in NOXA protein level after treatment with the combination of panobinostat and S-55746 for 24 hours. The drug had no effect on BCL2 levels.
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Panobinostat ( NSG mice (n = 8 per treatment group) were injected with PDX DLBCL and treated with either vehicle, panobinostat (5 mg/kg 5 times weekly), UMI-77 (60 mg/kg every other day), S-55746 (75 mg/kg 5 times weekly) or the 2 drugs together for 3 weeks. Differences between groups were calculated with the ANOVA with Dunnett's test. **P < 0.005, ***P < 0.001 B.
Kaplan-Meier plot of the percent survival as a function of time from last drug administration. Data are from n = 8 for all groups in PDX DLBCL tumors. **P < 0.005, ****P < 0.0001. 
